Clinical Trial Details

A Phase II Study of Inotuzumab Ozogamicin Followed by Blinatumomab for Ph-Negative, CD22-Positive B-Lineage Acute Lymphoblastic Leukemia in Newly Diagnosed Older Adults or Adults with Relapsed or Refractory Disease

Categories (click each to see list of all clinical trials associated with that category): Leukemia/MDS/MPD (ONC)

Current Status: Open

Phase: II

Principal Investigator: Gundabolu, Krishna

Contact Information:
Penny Hardiman, RN
402-559-4135
penny.hardiman@unmc.edu

Eligibility: https://www.clinicaltrials.gov/ct2/show/NCT03739814?cond=NCT03739814&draw=2&rank=1#eligibility

Summary